Thobois S - Search Results

1

Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial.

Lhommée E, Wojtecki L, Czernecki V, Witt K, Maier F, Tonder L, Timmermann L, Hälbig TD, Pineau F, Durif F, Witjas T, Pinsker M, Mehdorn M, Sixel-Döring F, Kupsch A, Krüger R, Elben S, Chabardès S, Thobois S, Brefel-Courbon C, Ory-Magne F, Regis JM, Maltête D, Sauvaget A, Rau J, Schnitzler A, Schüpbach M, Schade-Brittinger C, Deuschl G, Houeto JL, Krack P; EARLYSTIM study group. Lhommée E, et al. Among authors: thobois s. Lancet Neurol. 2018 Mar;17(3):223-231. doi: 10.1016/S1474-4422(18)30035-8. Lancet Neurol. 2018. PMID: 29452685 Clinical Trial.

2

Motor imagery in normal subjects and in asymmetrical Parkinson's disease: a PET study.

Thobois S, Dominey PF, Decety J, Pollak PP, Gregoire MC, Le Bars PD, Broussolle E. Thobois S, et al. Neurology. 2000 Oct 10;55(7):996-1002. doi: 10.1212/wnl.55.7.996. Neurology. 2000. PMID: 11061258

3

Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients.

Thobois S, Mertens P, Guenot M, Hermier M, Mollion H, Bouvard M, Chazot G, Broussolle E, Sindou M. Thobois S, et al. J Neurol. 2002 May;249(5):529-34. doi: 10.1007/s004150200059. J Neurol. 2002. PMID: 12021940 Clinical Trial.

4

The timing of antiparkinsonian treatment reduction after subthalamic nucleus stimulation.

Thobois S, Corvaisier S, Mertens P, Di Guardo C, Mollion H, Guenot M, Rochefort F, Chazot G, Sindou M, Broussolle E. Thobois S, et al. Eur Neurol. 2003;49(1):59-63. doi: 10.1159/000067028. Eur Neurol. 2003. PMID: 12464720

5

Effects of subthalamic nucleus stimulation on actual and imagined movement in Parkinson's disease : a PET study.

Thobois S, Dominey P, Fraix V, Mertens P, Guenot M, Zimmer L, Pollak P, Benabid AL, Broussolle E. Thobois S, et al. J Neurol. 2002 Dec;249(12):1689-98. doi: 10.1007/s00415-002-0906-y. J Neurol. 2002. PMID: 12529791

6

Tactile hallucinations in Parkinson's disease.

Fénelon G, Thobois S, Bonnet AM, Broussolle E, Tison F. Fénelon G, et al. Among authors: thobois s. J Neurol. 2002 Dec;249(12):1699-703. doi: 10.1007/s00415-002-0908-9. J Neurol. 2002. PMID: 12529792

7

Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease--A [(11)C]-raclopride PET study.

Thobois S, Fraix V, Savasta M, Costes N, Pollak P, Mertens P, Koudsie A, Le Bars D, Benabid AL, Broussolle E. Thobois S, et al. J Neurol. 2003 Oct;250(10):1219-23. doi: 10.1007/s00415-003-0188-z. J Neurol. 2003. PMID: 14586606 Clinical Trial.

8

Subthalamic nucleus stimulation and dysarthria in Parkinson's disease: a PET study.

Pinto S, Thobois S, Costes N, Le Bars D, Benabid AL, Broussolle E, Pollak P, Gentil M. Pinto S, et al. Among authors: thobois s. Brain. 2004 Mar;127(Pt 3):602-15. doi: 10.1093/brain/awh074. Epub 2004 Jan 21. Brain. 2004. PMID: 14736753

9

Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study.

Durif F, Debilly B, Galitzky M, Morand D, Viallet F, Borg M, Thobois S, Broussolle E, Rascol O. Durif F, et al. Among authors: thobois s. Neurology. 2004 Feb 10;62(3):381-8. doi: 10.1212/01.wnl.0000110317.52453.6c. Neurology. 2004. PMID: 14872017 Clinical Trial.

10

Globus pallidus internus stimulation in primary generalized dystonia: a H215O PET study.

Detante O, Vercueil L, Thobois S, Broussolle E, Costes N, Lavenne F, Chabardes S, Lebars D, Vidailhet M, Benabid AL, Pollak P. Detante O, et al. Among authors: thobois s. Brain. 2004 Aug;127(Pt 8):1899-908. doi: 10.1093/brain/awh213. Epub 2004 Jul 1. Brain. 2004. PMID: 15231585

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

244 results

Search Page